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Abstract 
Background and purpose: Ureteral stricture is a rare, but serious complication following 
ureteroscopy (URS) for stones. The aim of this study was to investigate how many patients 
ended up with a ureteral stricture after URS at our hospital and how these were treated. We 
also wanted to identify potential risk factors for post endoscopic stricture formation.  
Materials and methods: A retrospective evaluation of 1001 URS for stone treatment at the 
day-case surgery unit between 2013 - 2018 was performed. Data on pretreatment status, 
the surgical procedure and follow-up were recorded. Exact χ2 and independent-samples t-
tests were used comparing data among those who developed strictures and those who did 
not. Multiple logistic regression was performed analyzing risk factors for stricture formation.  
Results: In total, 1001 URS were performed in 725 patients, 289 women and 436 men. Of 
these, 995 cases were eligible for analysis. At follow-up with computed tomography after 3 
months, 28 (3.0%) strictures were identified. Of these, 20 received endourological treatment 
with balloon dilatation of which 15 (75%) were successful. Definitive treatment in the 13 
patients with failed or unattempted endourological treatment included nephrectomy, 
reconstructive surgery, permanent nephrostomy or observation with no further treatment. 
In multiple regression analysis, use of access sheath (UAS) (OR 4.6, p = 0.011), ureteral 
perforation (OR 11.8, p < 0.0001) and surgical time > 60 minutes (OR 5.7, p < 0.005) were 
found to be risk factors for stricture formation. 
Conclusion: Ureteral stricture is a rare complication of URS. Balloon dilatation should be the 
first line of treatment. Use of UAS, perforation and excessive operating time were found to 
be risk factors for post endoscopic ureteral stricture formation. Special attention to these 




A ureteral stricture is a narrowing of the ureter causing functional obstruction 1. This may 
cause pain, lead to a deterioration in renal function and hinder ureteral stones from passing 
spontaneously. It may also act as an obstacle for passage of an endoscope. Ureteroscopy 
(URS) is a known iatrogenic cause of strictures and risk factors in conjunction with this 
procedure include perforations and excessive operating time 1,2. In addition, URS performed 
by an inexperienced surgeon has been shown to increase the risk of complications 3,4. 
However, it is still unclear whether surgical experience also affects the risk of developing 
ureteral strictures.  
The introduction of small diameter endoscopes, lasers and auxiliary equipment is thought to 
have contributed to a reduction in the occurrence of post-endoscopic strictures in recent 
years, with current rates reported to be 0.3 - 4% 2,5-7. However, the role of ureteral access 
sheaths (UAS) in the development of ureteral strictures is still debated 8,9. 
The present study was planned with the aim of clarifying questions and identifying factors 
related to development of ureteral strictures following URS for stone disease. The main 
objective of this study was to determine how many patients ended up with a ureteral 
stricture after URS for urolithiasis at our hospital. Furthermore, we wanted to identify 
possible risk factors for post endoscopic stricture formation.  
Secondary aims were to point out possible specific causes for stricture development in each 






Materials and methods 
Setting, study population and data collection  
In October 2013, a new day-case surgery unit opened at Haukeland University Hospital 
(HUH) in Bergen, Norway. The URS procedures were reorganized from regular in-patient 
cases to being performed as day-cases in the new unit. 
As part of an internal quality evaluation of the endoscopic activity in our department, a 
retrospective review of all the retrograde ureteroscopic stone treatments performed in the 
day-case surgery unit since the opening in October 2013 until June 2018, has been done. The 
indications for URS were the same in the five-year time-frame, and there was no major 
change in the performance of the procedure or in the equipment used. 
In total, 1001 URS for stones were performed in 725 patients, 289 women and 436 men. The 
mean age at the time of endoscopy was 55 years (range 4 – 95 years). The patients’ general 
condition was assessed using the American Society of Anaesthesiologists Score (ASA-Score), 
with 2 being the median ASA-Score.   
A non-contrast computed tomography (CT) was performed prior to the URS. Stone size was 
defined as the largest diameter of the calculus. If multiple stones were present, the largest 
diameter of the biggest stone was registered. Preoperative obstruction was defined as 
presence of dilatation proximal to the stone seen on preoperative CT, persistent pain or 
finding of an impacted stone at the time of the URS. Table 1 presents the pre-treatment 
basic characteristics.  
The URS procedures were performed using either a semirigid endoscope (8F/9.8F tapering 
shaft, Richard Wolf Medical Instruments Corporation, Vernon Hills, IL), a flexible endoscope 
(URF-V-V3 or P6/P7, Olympus Corporation, Tokyo, Japan), or both. The decision to use a UAS 
or a safety guide wire (SGW) was entrusted to the surgeon in each case based on their 
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personal preferences. In these cases, either a 10/12 CH or 12/14 CH UAS (UroPass®, 
Olympus Corporation, Tokyo, Japan) was inserted depending on the flexible endoscope 
used, while a super stiff hydrophilic guide wire with floppy tip (SureGlide® 0.035”, Olympus 
Corporation, Tokyo, Japan) was the standard guide wire. It should be noted, however, that a 
sheath- and wireless procedure is routine at HUH. A holmium laser was utilized for 
fragmentation of the stone when deemed necessary, and fragments were retrieved with 
forceps, baskets or left in situ for spontaneous passage depending on the preferences and 
judgement of the urologist in each case.  
To achieve the best possible estimate of post endoscopic strictures, cases in which dilatation 
of a ureteral stricture was required in order to reach the level of the calculus prior to stone 
treatment, were excluded from further analysis. Characteristics of the URS procedures are 
presented in table 2.  
Follow-up with non-contrast CT was performed after three months. A post endoscopic 
ureteral stricture was defined as dilatation of the upper urinary tract proximal to a ureteral 
narrowing verified on CT or verified directly at a second URS. Ureteroscopically, a stricture 
was noted if the narrowing was not passable for the endoscope in a location where a 
stenosis or tapering of the ureteral lumen was not registered during the first endoscopy. If 
dilatation was noted at follow-up, the patient was scheduled for a second URS to verify the 
presence of a ureteral stricture and continue with endoscopic treatment if considered 
appropriate.  
Initial follow-up imaging was performed 3-6 months after the endoscopic treatment. 
Successful treatment was defined as regression of the dilatation seen on CT or ultrasound 
together with persistent relief of symptoms. Further follow-up was assessed in each case. In 
cases with persistent dilatation, a subsequent URS with a second attempt of endourological 
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treatment was performed. If still unsuccessful, an isotope renography was performed 
whenever there was doubt about renal function before reconstructive surgery, nephrectomy 
or permanent drainage. 
 
Statistics 
Independent-samples t-tests were performed comparing continuous variables, such as stone 
size and operating time. Categorical variables, such as sex and ASA-scores, were compared 
using exact chi-squared tests. Multiple regression analysis was performed to determine risk 
factors for ureteral stricture. 
IBM SPSS Statistics 25 (IBM, Armonk, NY) was used for statistical analysis. The p value was 
considered significant when < 0.05. 
 
Ethics 
The study was approved by The National Committees for Research Ethics in Norway (ID-no: 












During the study-period, 1001 URS were performed for the treatment of calculi. Six cases 
were excluded from further analysis because a ureteral stricture was identified and treated 
during the URS procedure before reaching the level of the stone. Of the remaining, 535 
(53.8%) were done for stones located in the renal pelvis, 348 (35.0%) for ureteral stones and 
112 (11.3%) for both renal and ureteral stones combined. The preoperative stone status is 
provided in Table 1. 
Follow-up after 3 months with a CT scan was registered in 947 cases (95.2%), and 28 (3.0%) 
strictures were identified. Figure 1 shows the stricture rate partitioned per year from 2013 
to 2018. The stricture rates were stable throughout the study period with a mean rate of 
1.8% per year, except 2017 when there was a peak in the number of strictures.  
Preoperative, operative and postoperative characteristics were compared for patients who 
developed a post endoscopic ureteral stricture and those who did not. There was no 
significant difference in the number of patients having obstruction prior to the URS in the 
stricture group compared to the non-stricture group, 13 (46.4%) and 305 (33.2%) cases 
respectively, p = 0.157. Preoperative treatment with a JJ-stent was significantly more 
frequent in the stricture group with 11 cases (39.3%) compared to the non-stricture group 
with 122 cases (13.3%), p = 0.001. This may be related to the trend of more patients in the 
stricture group having previous URS attempts for the same stone (10 cases, 35.7%) 
compared to the non-stricture group (211 cases, 23.0%), p = 0.170. 
Table 2 compares characteristics from the surgical procedures between patients who did not 
develop ureteral strictures and those who did. Two high volume endourologists performed 
more than half the number of procedures in addition to assisting residents in most of their 
URS. The remaining procedures were performed by another six urologists. 
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UAS was used almost exclusively when treating renal stones. Only two cases of ureteral 
stones required UAS. The opposite was found regarding SGW, which was used in three cases 
of renal stones and 16 cases with ureteral stone. 
In 21 cases (75.0%) the strictures occurred on the left side. Distal ureter was the 
predominant location for stricture formation followed by proximal and middle ureter in 12 
cases (42.9%), 11 cases (39.3%) and 5 cases (17.8%), respectively. Twenty-two strictures 
(78.6%) were less than < 2 cm long. 
Table 3 presents possible risk factors for development of ureteral strictures determined by 
multiple regression analysis. Use of UAS, intraoperative ureteral perforation and operating 
time above 60 minutes all increased the risk for post endoscopic stricture significantly.  
In most cases, more than one cause associated with stricture formation could be identified. 
In 20 cases (71.4%), events related to the URS procedure were registered as a possible cause 
of stricture development and impacted stones in 18 cases (64.3%). Previous radiation 
therapy as a contributing factor to stricture formation was registered in three cases (10.7%).  
Of the 28 patients who ended up with a ureteral stricture, endourological treatment was 
attempted in 21. Of these, 20 were treated with balloon dilatation. Fifteen patients (75.0%) 
were treated successfully with this procedure. Ten patients required a single treatment and 
five patients needed two consecutive URS procedures with balloon dilatation before 
persistent success. One patient had laser incision of the ureteral stricture as the only 
endourological treatment, which was unsuccessful. Endourological treatment was not 
successful in any of the patients with previous radiation therapy.  
Mean follow-up time was 14 months (range 1 - 42 months) in patients receiving 
endourological stricture treatment with a mean number of 3 follow-up consultations (range 
1 - 6). Mean follow-up time for the 15 patients with successful treatment with balloon 
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dilatation was 17 months (range 2 - 42 months), with 3 consultations (range 1 - 6). In the six 
patients with unsuccessful endourological treatment, the mean time from failed balloon 
dilatation or laser incision until final surgery was 8 months (range 1 - 15). 
Location of the stricture in the ureter was not related to successful management with 
balloon dilatation. On the other hand, strictures < 2 cm had significantly higher success rate 
after endourological treatment compared to strictures > 2 cm, 14 cases (87.5%) and 1 case 
(20.0%), respectively, p = 0.011.   
Definitive treatment in the 13 patients with failed or unattempted endourological 
treatment, include nephrectomy in four, reconstructive surgery in another five, permanent 
drainage with a nephrostomy tube in one and observation with no further treatment in the 
last three patients who all had severe comorbidities or were asymptomatic secondary to a 















By reviewing all the retrograde URS procedures performed for stones in the day-case surgery 
unit at HUH since the opening in October 2013, we have determined the incidence of post 
endoscopic ureteral strictures, identified risk factors for stricture formation and mapped out 
how the strictures were treated.   
At follow-up after 3 months, 28 strictures (3.0%) were identified. This is in accordance with 
other studies 5,6,8,10. The stricture rates were stable throughout the study period except a 
peak in the number of incidences in 2017. We could not point out any specific reason for this 
increase as the indications for URS, the performance of the endoscopy and the equipment 
used were unchanged during the study-period. 
The mechanisms of stricture formation following ureteroscopic stone treatment may be 
multifactorial and are not fully understood. Intraoperative ureteral injury and a long-term 
inflammation caused by impacted stones may be contributing factors 11. The inflammatory 
process following injury produces a fibrinous exudate that precipitates on traumatized areas, 
promoting adherence and ultimately stricture formation. In addition, periureteral fibrosis 
may also develop when urine is extravasated from the ureter, especially in the presence of 
infection 12. This means that any factor or event leading to ureteral wall injury is a potential 
risk factor for the development of ureteral stricture. 
Impacted stones are considered to be one of the main predictors of stricture formation 13,14. 
Detailed information regarding stone impaction was not available in the database. This data 
was retrieved from the patient charts for all patients who developed strictures. Preoperative 
obstruction may be an indication of the stone being impacted. However, dilatation may also 
be seen in stones that are unimpacted. This may explain why there was no significant 
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difference in the number of strictures at follow-up in patients with preoperative obstruction 
compared to those with no preoperative obstruction.  
Surprisingly, pretreatment with a JJ-stent was more frequent in patients who developed 
strictures. Pre-stenting has been demonstrated to reduce the risk of ureteral lesions during 
URS 15-17. Nevertheless, the protective properties of the stent might not fully have abolished 
the deleterious effects of an impacted stone in the present study, and may explain why 
more strictures occurred in the pre-stented patients. In addition, there was a trend towards 
more patients in the stricture group having had a previous procedure for the same stone 
compared to the non-stricture group. This may also explain the higher incidence of 
prestenting. Another trend that may have contributed to the higher pre-stenting rate in the 
stricture group was larger stone size and more stones located in the ureter in these patients. 
Three-quarters of the strictures were located in the left ureter. May et al. have suggested 
that the left ureter might have an anatomical or functional predisposition to obstruction as 
more strictures seem to occur on this side 2. This finding could not be confirmed in the 
present study. Nor could we identify a predilection site for strictures with regards to the 
level of the ureter. Castro and coworkers were also unable to demonstrate such an 
association 18. In most cases, the level of the strictures coincided with the location of the 
stones.  
Even though most strictures developed after treating stones in the ureter, we found no 
significant association between stricture formation and stone location. It is noteworthy that 
more than 35% of the strictures in our material were seen after URS for stones in the renal 
pelvis. This suggests that surgical technique is a major contributor to stricture formation.  
A SGW was used in 19 (2.0%) cases only, with no difference between patients who 
developed strictures and those who did not. The use of a SGW has not been considered 
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mandatory at HUH since URS was introduced in the early 1980s. In a previous study 
comparing URS for ureteral stones with and without a SGW, we could not demonstrate any 
difference in the number of intraoperative complications 7. However, the post endoscopic 
stricture rate was significantly higher when a SGW was used compared to when it was 
omitted 7. 
The use of UAS during URS is debated. Advocates for its use claim superior stone free rates 
(SFR), shorter operating time and lower intrarenal pressure 19,20. However, other studies 
have shown that insertion of UAS may lead to ureteral lesions 15. In addition, large cohort 
studies have shown no difference in the SFRs whether a UAS has been used or not 21. Due to 
these controversies, the EAU Guidelines on Urolithiasis state that the decision to use a UAS 
is up to the surgeon based on his or her preference 10. UAS was rarely used in the present 
study, and conclusions should therefore be drawn with caution. Nevertheless, significantly 
more strictures were found when a UAS was used compared to when it was omitted. The 
use of UAS was also found to be a significant risk factor for development of stricture in 
multiple regression analysis with an OR of 4.6, p = 0.011. In a randomized trial, Lallas et al. 
demonstrated a transient decrease in ureteral blood flow when a UAS was inserted 22. Even 
though blood flow returned to normal after a short period of time, the transiently impaired 
blood supply to the ureter may explain the higher rate of strictures when a UAS was used. 
Intraoperative perforation and excessive operating time were found to be significant risk 
factors for stricture formation. These findings are in accordance with other reports 1,2. The 
inflammatory response following a perforation may explain stricture formation. Excessive 
operating time might reflect a more complicated stone situation. In addition, an extended 
operating time undeniably causes reduced blood flow to the ureter either when dilatated by 
the endoscope, or even worse, by insertion of the bigger UAS.  
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On the other hand, surgical experience was not found to increase the risk of stricture 
formation. This finding is in contrast to the increased risk of complications in URS performed 
by inexperienced surgeons reported by others 3,4. An explanation may be that more 
complicated cases were operated by experienced surgeons in our series. 
In total, 20 of the 28 patients who developed strictures were treated with balloon dilatation, 
15 (75%) successfully. The success rate was higher when the strictures were < 2 cm 
compared to longer strictures. Both findings are in accordance with other studies 2,5.  
The retrospective design of this study is a limitation. This may have contributed to rough 
registration of data and underestimation of complications that could have affected the 
outcome. Incomplete renographic data makes it difficult to assess the renal function after 
endoscopic treatment. However, regression of dilatation and remission of symptoms may 
still indicate successful treatment. Furthermore, in cases of persistent dilatation or pain, 
patients were investigated with a subsequent URS or an isotope renography. The added 
diagnostic value of controlling all stricture patients with an isotope renography may 
therefore be questioned in the present study. 
Detailed data on stone impaction was only available for patients who developed strictures. 
This limitation has prevented us from including stone impaction as an independent risk 
factor in the multiple logistic regression analysis. Another limitation is the relatively low 
number of strictures. This may have caused important risk factors to falsely turn out as 
nonsignificant in the analyses. In addition, the low number of adverse events make adjusted 
analyses of the background characteristics difficult. Despite the relatively low number of 





Ureteral stricture is a rare, but serious complication following URS. Our study suggests that 
endourological balloon dilatation should be the first line treatment, with an expected 
success rate of about 75%. Risk factors for post endoscopic ureteral stricture formation were 
found to be use of UAS, perforation and excessive operating time. Special attention to these 
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Figure 1 Ureteral stricture rates per year throughout the study period 
 
 
In 2013, only procedures performed between October and December were included. In 















Table 1 Preoperative characteristics 
Characteristics   
Side of treatment    
 Right  427 (42.9%) 
 Left  568 (57.1%) 
    
Stone status    
          Renal pelvis Size in mm - mean (95% CI) 8.7 (8.3 - 9.0) 
          (n=647) Number of stones    1 336 (51.9%) 
     2 112 (17.3%) 
     3 60 (9.3%) 
  > 3 139 (21.5%) 
    
          Ureter Size in mm - mean (95% CI) 7.4 (7.1 - 7.7) 
          (n=460) Number of stones    1 395 (85.9%) 
     2 37 (8.0%) 
     3 6 (1.3%) 
  > 3 22 (4.8%) 
 Location* proximal 150 (32.6%) 
  middle 57 (12.4%) 
  distal 265 (57.6%) 
    
Obstruction prior to URS (dilatation on CT) 330 (33.2%) 
  
Pre-stented with JJ   140 (14.1%) 













Table 2 Comparison of characteristics related to the URS procedure 
Characteristics No stricture Stricture p-value 
Stone location    
 Renal pelvis 502 (54.6%) 10 (35.7%) 
0.121  Ureter 318 (34.6%) 14 (50.0%) 
 Both renal pelvis and ureter 99 (10.8%) 4 (14.3%) 
     
Stone size in mm - mean (95% CI)    
 Renal pelvis 8.7 (8.3 - 9.1) 10.5 (6.3 - 14.7) 0.371 
 Ureteral 7.4 (7.1 - 7.7) 9.5 (6.9 - 12.1) 0.104 
     
Operator experience    
 Resident 242 (26.3%) 6 (21.4%) 
0.476  Consultant 201 (21.9%) 4 (14.3%) 
 Endourologist 476 (51.8%) 18 (64.3%) 
     
Endoscopes    
 Semirigid only 202 (22.0%) 9 (32.1%) 
0.155  Flexible only 56 (6.1%) 3 (10.7%) 
 Semirigid and flexible 661 (71.9%) 16 (57.2%) 
    
Safety guide wire 18 (2.0%) 1 (3.6%) 0.438 
     
Access sheath 32 (3.5%) 5 (17.9%) 0.004 
     
Stone fragmentation and retrieval    
 Dusting/fragmentation only 403 (43.9%) 6 (21.4%) 
0.020 
 Fragmentation and retrieval 516 (56.1%) 22 (78.6%) 
     
Intraoperative complications*    
 Total cases 74 (8.1%) 9 (32.1%) < 0.0005 
 Disturbing bleeding 59 (6.4%) 5 (17.9%) 0.035 
 Perforation 25 (2,7%) 6 (21.4%) < 0.0005 
 Mucosal abrasion 20 (2.2%) 2 (7.1%) 0.135 
     
Post endoscopic drainage with JJ-stent 677 (73.7%) 26 (92.9%) 0.026 
     
Operating time - minutes (95%CI) 51.5 (49.9 - 53.1) 72.1 (62.2 - 82.0) < 0.0005 
* Disturbing bleeding was registered as a complication when vision was impaired to an 
extent that hindered further endoscopy. Perforation was assessed endoscopically or as 
contrast leakage on retrograde pyelogram. Mucosal abrasion was defined as grade 2 or 







Table 3 Multiple logistic regression analysis of potential risk factors for ureteral stricture      
              development 
 
Risk factor OR 95% CI for OR p-value 
Stone related factors    
 Stone location (ureter vs renal pelvis) 2.4 0.9 - 6.6 0.090 
 Stone burden 1.5 0.7 - 3.6 0.333 
     
Preoperative factors    
 Obstruction prior to URS 1.1 0.4 - 2.9 0.801 
     
Factors related to the URS procedure    
 Previous URS for same stone 1.7 0.7 - 4.2 0.233 
 Operator experience (resident vs urologist) 0.6 0.2 - 1.6 0.275 
 Access sheath 4.6 1.4 - 14.6 0.011 
 Fragmentation and retrieval vs dusting 2.7 1.0 - 7.6 0.059 
 Perforation 11.8 3.8 - 36.6 < 0.0001 
 Operating time ≥ 60 minutes 5.7 2.2 - 15.2 < 0.0005 
 
